Spelling suggestions: "subject:"emergency medicine"" "subject:"emergency edicine""
161 |
Pediatric EmergenciesDodd, Will 01 August 2018 (has links)
No description available.
|
162 |
Pediatric EmergenciesDodd, Will 01 May 2020 (has links)
No description available.
|
163 |
An Ethically Informed Consideration of the Use of a Waiver of Informed Consent in Emergency Medicine ResearchKing, Hillary S. 13 June 2013 (has links)
No description available.
|
164 |
Understanding Video Laryngoscope Screen Visualization Patterns in the Pediatric Emergency Department and the Impact on Procedural PerformanceDean, Preston 28 June 2021 (has links)
No description available.
|
165 |
Protocol Based Screening Tools to Identify Sepsis Patients Transported by Emergency Medical ServicesMoser, Isaiah 01 January 2017 (has links)
Sepsis is a complicated disorder in which an infection has reached the bloodstream and caused a cascade of events that in time will lead to death. Interventions aimed at identifying sepsis early in its progression are imperative to stopping the process. The purpose of this study is to examine the current state of the literature regarding sepsis screening tools utilized by emergency medical services. A literature review exploring the various tools in place was conducted to see their value in predicting sepsis and secondary what the initiation of a sepsis alert has on the patients’ outcome. Results found included that sepsis screening tools when in place decrease time to identification, decrease time to antibiotics, increase amount of fluid administration, and overall reduce hospital stay and mortality rate. With these findings educational training for EMS providers and the introduction of generalized protocols are of the upmost importance. Further research is needed to be done to create a consistent tool to be used by all EMS agencies that has a validated predictive value of sepsis.
|
166 |
A Non-invasive Prototype Device for Detecting Intracerebral HemorrhageKorfhagen, Joseph J. 27 October 2014 (has links)
No description available.
|
167 |
Emergency pain management: trends and efficacyBlackwell, Christopher W. 01 October 2001 (has links)
No description available.
|
168 |
Revisión crítica: cuidados de enfermería a pacientes con cetoacidosis diabética en el servicio de emergenciaPizarro Coronado, Luz Bella January 2024 (has links)
El trabajo académico titulado "Cuidados de Enfermería a Pacientes con Cetoacidosis Diabética en el Servicio de Emergencia" es de naturaleza secundaria, el objetivo fue identificar los cuidados de enfermería proporcionados en el servicio de emergencia a pacientes con cetoacidosis diabética. La metodología de enfermería basada en la evidencia (EBE) se utilizó en este estudio. La pregunta clínica se realizó siguiendo el esquema PICOT: ¿Cuáles son los cuidados de Enfermería proporcionados a los pacientes con cetoacidosis diabética en el servicio de Emergencia? En este estudio bibliográfico, se emplearon recursos como la biblioteca virtual ALICIA, Google Académico, BVS, Dialnet y SCIELO, de donde se extrajeron diez artículos. Estos artículos fueron posteriormente evaluados mediante la lista de validación propuesta por Gálvez Toro, resultando en la selección de dos artículos. Se optó por una guía de práctica clínica basada en evidencia, utilizando la metodología GRADE Adolpment y la lista AGREE II, donde el nivel de evidencia es IA. Encontrando los siguientes cuidados: Monitoreo periódico cada 4 horas, Controlar los niveles de glucosa en un rango de 140 a 180 mg/dL, Monitoreo continuo de la diuresis en con la posibilidad de colocar una sonda urinaria si es necesario, Administración inicial de NaCl 0,9% a 1000 ml/h para corregir el shock hipovolémico, seguido por NaCl 0,9% a 500 mL/h durante 4 horas y luego continuar a 250 mL/h. Estos cuidados son esenciales para el manejo de la cetoacidosis diabética en el entorno de emergencia. / The academic work entitled "Nursing Care of Patients with Diabetic Ketoacidosis in the Emergency Department" is secondary in nature, the objective was to identify the nursing care provided in the emergency department to patients with diabetic ketoacidosis. Evidence-based nursing (EBN) methodology was used in this study. The clinical question was conducted following the PICOT scheme: What is the nursing care provided to patients with diabetic ketoacidosis in the emergency department? In this bibliographic study, resources such as the ALICIA virtual library, Google Scholar, BVS, Dialnet and SCIELO were used, from which ten articles were extracted. These articles were subsequently evaluated using the validation list proposed by Gálvez Toro, resulting in the selection of two articles. An evidence-based clinical practice guideline was chosen, using the GRADE Adolpment methodology and the AGREE II list, where the level of evidence is IA. Finding the following care: Periodic monitoring every 4 hours, Controlling glucose levels in a range of 140 to 180 mg/dL, Continuous monitoring of diuresis with the possibility of placing a urinary catheter if necessary, Initial administration of NaCl 0.9% at 1000 mL/h to correct hypovolemic shock, followed by NaCl 0.9% at 500 mL/h for 4 hours and then continue at 250 mL/h. This care is essential for the management of diabetic ketoacidosis in the emergency setting.
|
169 |
The role of calcium and calcium antagonists in the reperfusion injury of the heartConradie, Suzanne Louise January 2005 (has links)
Thesis (PhD)--Stellenbosch University, 2005. / ENGLISH ABSTRACT: The reperfusion injury after myocardial ischemia is relevant in the clinical setting,
after cardiopulmonary bypass for cardiac surgery, after PTCA and stenting and
after cardiopulmonary resuscitation. The components of the reperfusion injury
considered in this study were myocardial stunning and reperfusion arrhythmias.
Calcium antagonists have been shown to be beneficial in attenuating the
myocardial reperfusion injury in the in vitro and in vivo laboratory setting
(Lamping, Gross 1985, Przyklenk and Kloner 1988, Taylor 1990, Ehring 1992,
Gross and Piper 1992). However systemic administration of a dose of calcium
antagonist, large enough to attenuate the myocardial reperfusion injury in the
clinical setting, would inevitably lead to unwanted systemic side effects of the
drug.
The aim of this study was to investigate the hypothesis that an adequate dose of
verapamil administered timeously, directly into the ischemic myocardium, would
attenuate the reperfusion injury, either when administered from the onset of
ischemia, or from 3 minutes before reperfusion.
The anesthetized open chest porcine model of myocardial ischemia (15 min total
LAD occlusion) and reperfusion was employed in this study. A low dose of
verapamil (0.5 mg/8mt or 0.0625mg/mt), a high dose of verapamil (2mg/8m or O.25mg/ml), or vehicle (saline) (8ml) was infused over 8 minutes, directly into
the LAD coronary artery supplying the ischemic segment. The infusion was
started either at the onset of ischemia, or from 3 minutes before reperfusion.
The time taken for the various parameters to return to pre ischemic values was
compared between the different groups.
The results showed that the high dose of verapamil (2mg) attenuated the
reperfusion injury both when administered from the onset of ischemia, and when
administered from 3 minutes before reperfusion, compared to either the low dose
of verapamil, or the saline infusions. The high dose of verapamil groups had a
faster recovery of both systolic contractile function and diastolic function and a
lower incidence of ventricular fibrillation on reperfusion. There were no systemic
effects of verapamil infusion in any of the groups.
The clinical setting of cardiac surgery expressly lends itself to the clinical
application of this finding. There is direct access to the coronary arteries both
before ischemia and before reperfusion. A small dose of calcium channel
blocking drug, with no systemic effect can be administered into the aortic root at
the onset of ischemia, just prior to cardioplegia (when the heart is still warm),
and after rewarming a few minutes prior to removal of the aortic cross clamp. / AFRIKAANSE OPSOMMING: Die reperfusie besering na miokardiale isgemie is klinies relevant na
kardiopulmonêre omleiding vir hart chirurgie, na kardiologiese PTKA en stut
prosedures en na kardiopulmonale ressussitasie. Die komponente van die
reperfusie besering wat in hierdie studie oorweeg is, is miokardiale tydelike
omkeerbare onderdrukking (stunning) en reperfusie arritmieë.
Kalsium antagoniste is gewys om effektief te wees in beperking van die
reperfusie besering in beide in vitro en in vivo laboratorium eksperimente
(Lamping, Gross 1985, Przyklenk en Kloner 1988, Taylor 1990, Ehring 1992,
Gross en Piper 1992). Sistemiese toediening van 'n dosis kalsium kanaal
blokker, voldoende om die miokardiale reperfusie besering in die pasiënt te
beperk, lei egter tot ongewenste sistemiese newe effekte van die middel.
Die doel van die studie was om die hipotese te ondersoek dat 'n voldoende dosis
verapamil, wat betyds direk toegedien is aan die isgemiese miokardium, die
reperfusie besering sal beperk, ongeag of dit toegedien is vanaf die begin van
isgemie, of van 3 minute voor reperfusie.
Die vark model van miokardiale isgemie en reperfusie is aangewend in die studie.
Die varke was tydens die eksperiment onder narkose, met die borskas oop, en
15 minute totale LAD okklusie is toegepas. 'n Lae dosis verapamil (0.5mg/8ml of 0.0625 mg/mt), of hoë dosis veraparnil (2mg/8mt of 0.25mg/mt), of saline
(8mt) is oor 8 minute toegedien direk in die LAD arterie wat die isgemiese
segment voorsien. Die infuus is begin direk na die aanvang van isgemie, of 3
minute voor die aanvang van reperfusie. Die tyd geneem vir terugvoer van
parameters na pre isgemiese waardes is tussen die groepe vergelyk.
Die resultate toon dat die hoë dosis veraparnil die reperfusie besering beperk in
vergelyking met die lae dosis veraparnil of saline infusies, ongeag of dit van die
begin van isgemie, of van 3 minute voor reperfusie toegedien word. Die groepe
wat die hoë dosis veraparnil ontvang het, het vinniger herstel van sistoliese en
diastoliese funksie getoon en het'n laer insidensie van reperfusie disritmieë,
gewys. Geen sistemiese effekte van veraparnail infuus is waargeneem nie.
Die kliniese toepassing van hierdie bevinding is by uitstek geskik vir toepassing
tydens kardiopulmonale omleiding by kardiale chirurgie. Daar is direkte toegang
tot koronêre arteries voor isgemie en voor reperfusie. 'n Klein dosis kalsium
antagonis, met weglaatbare sistemiese effekte, kan toegedien word in die aorta
wortel met die aanvang van isgemie, net voor kardioplegie toediening (hart
steeds warm), en na verwarming, 'n paar minute voor verwydering van die aorta
kruis klem.
|
170 |
An investigation into the non-compliance of advanced life support practitioners with the guidelines and protocols of the Professional Board for Emergency Care PractitionersChristopher, Lloyd Denzil January 2007 (has links)
Thesis (M.Tech.: Emergency Medical Care)-Durban University of Technology, 2007
xiv, 116 leaves / The Professional Board for Emergency Care Practitioners (PBECP), a division of the Health Professions Council of South Africa, regulates the scope of practice and publishes guidelines and protocols that advanced life support (ALS) practitioners are required to follow. These define an acceptable, standardised approach to each commonly encountered emergency. Non compliance with the guidelines and protocols regularly occurs, which could impact on the quality of care delivered and may result in further injury or death of the patient. This study investigated the reasons for non-compliance by ALS practitioners and explored how compliance could be improved.
|
Page generated in 0.0611 seconds